Be an early applicantLess than 25 applicants
AVEO Oncology · 2 days ago
Vice President of Biostatistics
Boston, MA
Full-time
Onsite
Executive
10+ years exp
Wonder how qualified you are to the job?
Maximize your interview chancesBiotechnologyHealth Care
Insider Connection @AVEO Oncology
Responsibilities
Provide strategic direction and leadership to the biostatistics team, ensuring alignment with corporate goals and objectives.
Develop and implement statistical strategies for clinical development programs, ensuring robust and innovative statistical methodologies are applied.
Lead the statistical component of regulatory submissions, including the preparation of statistical analysis plans, clinical study reports, and responses to regulatory agency queries.
Oversee the analysis and interpretation of clinical trial data, ensuring the accuracy, validity, and integrity of statistical outputs.
Serve as a key point of contact for internal and external stakeholders on biostatistical matters.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Ph.D. or equivalent in Biostatistics, Statistics, or a related field.
Minimum of 10 years of experience in biostatistics within the biotechnology or pharmaceutical industry, with a focus on oncology.
Extensive experience with regulatory submissions and interactions with global regulatory agencies.
Proven leadership experience, including managing and developing high-performing teams.
Deep expertise in statistical methodologies and their application to clinical trials in oncology.
Strong knowledge of regulatory requirements and guidelines for clinical development.
Excellent leadership, communication, and interpersonal skills.
Ability to work effectively in a cross-functional, collaborative environment.
Strong problem-solving and analytical skills with a keen attention to detail.
Preferred
Experience with late-and early phase clinical trials and market authorization applications.
Demonstrated ability to drive innovation in statistical approaches and trial design.
Strong publication record in peer-reviewed journals.
Company
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$560.85MKey Investors
Hercules CapitalNew Enterprise AssociatesVenrock
2022-10-18Acquired· by LG Chem ($566M)
2021-03-22Post Ipo Equity· $55.2M
2020-08-10Post Ipo Debt· $35M
Leadership Team
Michael P. Bailey
President & Chief Executive Officer
Edgar Braendle
Chief Medical Officer and Formation of Scientific Advisory Committee
Recent News
Google Patent
2024-04-14
2024-04-14
2024-04-14
Company data provided by crunchbase
